Saudi Arabia Pharmaceutical Market 2021– By Trends, Revenue and Forecast Till 2026 - PowerPoint PPT Presentation

About This Presentation

Saudi Arabia Pharmaceutical Market 2021– By Trends, Revenue and Forecast Till 2026


Some key players in the Saudi Arabia pharmaceutical market covered in this report are SPIMACO, Tabuk Pharmaceuticals Manufacturing Co., Juphar, Jamjoom Pharma, GlaxoSmithKline plc. Pfizer Inc., Novartis AG and Sanofi. – PowerPoint PPT presentation

Number of Views:260
Slides: 11
Provided by: Umesh213
Category: Other


Transcript and Presenter's Notes

Title: Saudi Arabia Pharmaceutical Market 2021– By Trends, Revenue and Forecast Till 2026


Saudi Arabia Pharmaceutical Market Trends 2021
Segmentation, Outlook, Industry Report to 2027
FMI Report
  • March 2021

Report Id REP-GC-1733Published On
2016-08-02Category Healthcare, Pharmaceuticals
Medical Devices
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
Saudi Arabia Pharmaceutical Market Analysis
In 2016, the Saudi Arabia pharmaceutical market
is anticipated to procure value worth US 5,209.5
Mn at a y-o-y growth of 6.0 over 2015. The
mounting demand for branded drug products will
continue to incite the growth of the Saudi
Arabian pharmaceutical market in 2016. Saudi
Arabia pharmaceutical market is estimated to be
valued at US 5,209.5 Mn by 2016 end and is
expected to expand at a CAGR of 9.0 over the
forecast period (2016-2026). This study
demonstrates market dynamics and trends that
influence the current environment and future
status of the pharmaceutical market in Saudi
Arabia over the forecast period.
  • Key Companies
  • Tabuk Pharmaceuticals Manufacturing Co.
  • Julphar
  • Jamjoom Pharma
  • Glaxosmithkline plc.
  • Pfizer Inc.
  • Novartis AG
  • Sanofi

Saudi Arabia Pharmaceutical Market Analysis
Impact of Covid-19 pandemic on market Due to the
outbreak of Covid-19 pandemic globally, imaging
modalities is widely preferred by most healthcare
professionals as it provides a primary diagnosis
in a short time. All the imaging technologies
involving nuclear imaging have been used
exhaustively to study Covid-19 and its effect on
different patients in each demography. The
increasing requirement for advanced imaging
solutions is projected to drive the development
studies globally. The report will account for
Covid19 as a key market contributor. Download
Sample Copy_at_ https//
Report Description The report examines Saudi
Arabia pharmaceutical market for the period
2016-2026. The primary objective of the report is
to offer insights on various products such as
prescription products, branded drugs, generic
drugs and over-the-counter (OTC) products.
Saudi Arabia Pharmaceutical Market Analysis
The report begins by defining various economic
and healthcare indicators in the country,
followed by an overview of dynamics of the Saudi
Arabia pharmaceutical market, which includes FMI
analysis of key trends, drivers, restraints and
opportunities and key players. It also includes
insights into key regulations and reimbursement
scenario. Impact analyses of key growth drivers
and restraints based on the weighted average
model have also been included in the report to
better equip readers with meaningful insights on
ongoing developments in the market. Primary
factors fuelling growth of the Saudi Arabia
pharmaceutical market include increasing
population and expatriates coupled with rapidly
increasing healthcare infrastructure and
proactive measures by the government to improve
the healthcare systems in the country. Other
factors driving demand for pharmaceuticals in
Saudi Arabia are rising prevalence of lifestyle
diseases and availability of better quality
products from multinational companies. On the
contrary, factors such as lack of research and
development capabilities and challenging
regulatory environment in Saudi Arabia are
factors expected to hamper market growth in the
near future. Based on product type, the market
has been segmented into prescription products and
OTC products. A detailed analysis has been
provided for every segment in terms of market
size, Y-o-Y growth rate, absolute opportunity
and BPS analysis.
Saudi Arabia Pharmaceutical Market Analysis
Based on disease type, the market has been
segmented into cardiovascular diseases, diabetes,
cancer, obesity, infectious diseases and other
diseases. A detailed analysis has been provided
for every segment in terms of market size, Y-o-Y
growth rate, absolute opportunity and BPS
analysis. Ask an Analyst _at_ https//www.futuremark
On the basis of distribution channel, retail
pharmacies segment is expected to witness highest
growth in Saudi Arabia pharmaceutical market over
the forecast period. This trend is expected to be
particularly prominent in Saudi Arabia, where
doctors and patients hold higher preference for
branded drugs over generic drugs. However,
hospital pharmacies segment is expected to
exhibit significant growth over the forecast
period due to demand for generic drugs fuelled by
increase in health insurance penetration.
Saudi Arabia Pharmaceutical Market Analysis
The above sections -- by product type, diseases
and distribution channel-- evaluate the present
scenario and growth prospects of the Saudi Arabia
pharmaceutical market for 2016-2026. We have
considered 2015 as the base year and provided
data for the forecast period. In addition, it is
imperative to note that in an ever-fluctuating
developing economy, we not only conduct forecasts
in terms of CAGR, but also provide analysis based
on key parameters such as year-on-year (Y-o-Y)
growth rates to understand the predictability of
the market and to identify the right
opportunities across the market. The Saudi
Arabia pharmaceutical market in terms of product,
diseases and distribution channel are analyzed in
terms of Basis Point Share (BPS) to understand
individual segment's relative contributions to
market growth. This detailed level of information
is important for identifying various key trends
in the pharmaceutical market. Another key
feature of this report is the analysis of key
segments in terms of absolute dollar opportunity.
This is traditionally overlooked while
forecasting the market. However, absolute dollar
opportunity is critical for assessing the level
of opportunity that a provider can look to
achieve, as well as to identify potential
resources from a sales and delivery perspective
of the pharmaceutical market.
Saudi Arabia Pharmaceutical Market Analysis
In the final section of the report, competitive
landscape of the coronary stents market is
included to provide report audiences with a
dashboard view, based on categories of providers
in the value chain, their respective product
portfolios and key developments. Key categories
of providers covered in the report are drug
manufacturers and distributors in the country.
This section is primarily designed to provide
clients with an objective and detailed
comparative assessment of key providers specific
to a market segment in the pharmaceutical market
value chain and potential players for the same.
Report audiences can gain segment-specific vendor
insights to identify and evaluate key competitors
based on in-depth assessment of capabilities and
successes in the Saudi Arabia pharmaceutical
market. Buy Report Now _at_ https//www.futuremarket Detailed profiles of
the providers are also included in the scope of
the report to evaluate their long-term and
short-term strategies, key offerings, SWOT
analysis and recent developments in the KSA
pharmaceuticals market. Key manufacturers
included in the report are SPIMACO, Tabuk
Pharmaceuticals Manufacturing Co., Julphar,
Jamjoom Pharma, Glaxosmithkline plc. Pfizer Inc.,
Novartis AG and Sanofi.
To know more about us, please visit our website For sales queries
or new topics email us on sales_at_futuremarketinsi For media queries, contact the press
office at For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)